Raymond Cha Pharm.D.

Raymond Cha Pharm.D.

Associate Professor (Clinical)



Office location

EACPHS, Room 4128 and Oakwood Hospital


Pharmacy Practice


Assistant Professor, Department of Pharmacy Practice

Degrees and Certifications

B.S. Pharmacy State University of New York at Buffalo

Pharm.D. State University of New York at Buffalo

ASHP ID Residency Veterans Affairs Medical Center

ACCP ID Fellowship Anti-Infective Research Laboratory, Wayne State University and Detroit Medical Center

Positions and Employment

Adjunct Clinical Professor of Medicine

Infectious Diseases Clinical Specialist

Director, Antimicrobial and Antifungal PK/PD Laboratory

Professional Memberships

Infectious Diseases Society of America
American Society for Microbiology
Society of Infectious Diseases Pharmacists
American College of Clinical Pharmacy
American Society of Health-System Pharmacists

Areas of Expertise

Infectious Diseases including special popoulations (HIV, BMT/transplant, TB)

Pharmacokinetic modeling

Pharmacodynamic modeling

Primary Research Interest

Antimicrobial pharmacodynamics

Antimicrobial pharmacokinetics

Antimicrobial stewardship

Recent Publications

Cha R, Rybak MJ.
Influence of protein binding under controlled conditions on the bactericidal activity of daptomycin in an in vitro pharmacodynamic model.
Journal of Antimicrobial Chemotherapy. 2004 Jul;54(1):259-62

Cha R, Rybak MJ.
Daptomycin against multiple drug-resistant staphylococcus and enterococcus isolates in an in vitro pharmacodynamic model with simulated endocardial vegetations.
Diagnostic Microbiology and Infectious Disease. 2003 Nov;47(3):539-546

Coyle EA, Cha R, Rybak MJ.
Influences of Linezolid (L), Penicillin (P), and Clindamycin (C), Alone and in Combination, on Streptococcal Pyrogenic Exotoxin A (SPE A) Release.
Antimicrobial Agents and Chemotherapy. 2003 May;47(5):1752-5

Cha R, Brown WJ, Rybak MJ.
Bactericidal Activities of Daptomycin, Quinupristin-Dalfopristin, and Linezolid against Vancomycin-Resistant Staphylococcus aureus in an In Vitro Pharmacodynamic Model with Simulated Endocardial Vegetations.
Antimicrobial Agents and Chemotherapy. 2003 Dec;47(12):3960-3

Cha R, Grucz RG, Rybak MJ.
Daptomycin Dose-Effect Relationship against Resistant Gram-Positive Organisms.
Antimicrobial Agents and Chemotherapy. 2003 May;47(5):1598-603

Cha R, Akins RL, Rybak MJ.
Evaluation of the Activities of Different Linezolid (LZD) Dosing Regimens Compared to Levofloxacin (LEV) and Vancomycin (VAN) against Multi-drug Resistant and Vancomycin-tolerant S. pneumoniae in an In Vitro Pharmacodynamic Model (IVPM).
Pharmacotherapy. 2003 Dec;23(12):1531-7

Cha R, Rybak MJ.
Linezolid and Vancomycin, Alone and in Combination with Rifampin, Versus Moxifloxacin Against Multi-Drug Resistant and Vancomycin-Tolerant Streptococcus pneumoniae (VTSP) in an In Vitro Pharmacodynamic Model (IVPM).
Antimicrobial Agents and Chemotherapy. 2003 Jun;47(6):1984-7

DiCenzo R, Forrest A, Squires KE, Hammer SM, Fischl MA, Wu H, Cha R, Morse GD; Adult AIDS Clinical Trials Group Protocol 368/886 Study Team.
Indinavir, efavirenz, and abacavir pharmacokinetics in human immunodeficiency virus-infected subjects.
Antimicrobial Agents and Chemotherapy. 2003 Jun;47(6):1929-35

Research Connect link


Return to profile list

150 years in the heart of Detroit